Skip to main content

Day: October 10, 2025

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 78,975 shares of its common stock and granted an aggregate of 54,475 restricted stock unit (“RSU”) awards to 20 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4). The 2021 Inducement Plan is used exclusively for granting equity awards to individuals who were not previously employees of Crinetics, or...

Continue reading

MidWestOne Financial Group, Inc. Announces Third Quarter 2025 Earnings Conference Call

IOWA CITY, Iowa, Oct. 10, 2025 (GLOBE NEWSWIRE) — MidWestOne Financial Group, Inc. (Nasdaq: MOFG) (“MidWestOne” or the “Company”), parent company of MidWestOne Bank, today announced that its third quarter 2025 financial results will be released after market closes on Thursday, October 23, 2025. The Company will host a conference call to discuss its financial results at 11:00 a.m. Central Time on Friday, October 24, 2025. Investors and analysts interested in participating in the call may pre-register utilizing the following link: https://www.netroadshow.com/events/login?show=414319b0&confId=80379. After pre-registering for this event, you will receive your access details via email. On the day of the call, you are also able to dial 1-833-470-1428 (callers located in Canada please dial 1-833-950-0062) approximately 15 minutes...

Continue reading

Credicorp Ltd.: Credicorp Held Investor Day Marking 30 Years on NYSE and Presented Vision for a Future-Ready Financial Ecosystem

Investor day highlights: transformation, innovation, and strong TSR across cycles. Reiterates aim to achieve sustainable ROE of 19.5% and a C/I ratio near 42% in the next three to four years. Lima, Oct. 10, 2025 (GLOBE NEWSWIRE) — Lima, Peru, October 10, 2025 – (“Credicorp” or “the Company”) (NYSE: BAP | BVL: BAP), the leading financial services holding company in Peru with a presence in Chile, Colombia, Bolivia, Panama and United States yesterday hosted its 2025 Investor Day in New York, marking the 30th anniversary of its listing on the New York Stock Exchange. The event convened senior leadership, institutional investors, and analysts to present its long-term roadmap for sustainable growth and reflect on how Credicorp has evolved into a more integrated and purpose-driven financial group. Chairman Luis Enrique Romero opened...

Continue reading

Norwood Financial Corp Announces Timing of Third Quarter 2025 Earnings Release and Conference Call 

HONESDALE, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) — Norwood Financial Corp (Nasdaq Global Market-NWFL) and its subsidiary, Wayne Bank, will release its third quarter 2025 financial results before market opens on Wednesday, October 22, 2025. On the same day, the Company will host a webcast and conference call at 9:00 a.m. ET to discuss the financial results. To participate in the live call, you may register and connect via webcast using this link: https://register-conf.media-server.com/register/BIb0fd881de5ac4aeeb442a8dced8ca6b4. Upon registering, dial-in info and a unique pin to join the call will be provided, as well as an email confirmation with details. A slide presentation will simultaneously be available for download on the Investor Relations website at ir.wayne.bank. A replay of the event, as well as a transcript, can be accessed...

Continue reading

Solitron Devices, Inc. Announces Fiscal 2026 Second Quarter Results

WEST PALM BEACH, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) — Solitron Devices, Inc. (OTC Pink: SODI) (“Solitron” or the “Company”) is pleased to announce fiscal 2026 second quarter results.  FISCAL 2026 SECOND QUARTER HIGHLIGHTS –Net sales increased 11% to approximately $3.99 million in the fiscal 2026 second quarter versus $3.58 million in the fiscal 2025 second quarter. Net bookings increased 147% to $4.32 million in the fiscal 2026 second quarter versus $1.75 million in the prior year second quarter. Backlog increased 146% to $18.64 million at the end of the fiscal 2026 second quarter as compared to $7.57 million at the end of the fiscal 2025 second quarter. Net income (loss) was ($0.23) million, or ($0.11) per share, for the fiscal 2026 second quarter versus net income of $0.02 million, or $.01 per share, for the fiscal 2025 second...

Continue reading

Hingham Savings Reports Third Quarter 2025 Results

HINGHAM, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced results for the quarter ended September 30, 2025. Earnings Net income for the quarter ended September 30, 2025 was $17,295,000 or $7.93 per share basic and $7.85 per share diluted, as compared to $5,846,000 or $2.68 per share basic and $2.66 per share diluted for the same period last year. The Bank’s annualized return on average equity for the third quarter of 2025 was 15.15%, and the annualized return on average assets was 1.54%, as compared to 5.52% and 0.54% for the same period last year. Net income per share (diluted) for the third quarter of 2025 increased by 195.1% compared to the same period in 2024. Core net income for the quarter ended September 30, 2025, which represents net income excluding...

Continue reading

WiSA Fortifies Offerings and Strategy to Further Address Growing Home Audio Categories with Low-Cost Transmitter Module, WiSA Connect Mobile Application, and Interoperability Self-Certification Process

New WiSA solutions reduce cost and improve time-to-market for products in the growing soundbar, home theater, home speakers, and TV markets, focusing on high-quality sound, and immersive multichannel audio. BEAVERTON, Ore., Oct. 10, 2025 (GLOBE NEWSWIRE) — Datavault AI (NASDAQ: DVLT), through its Acoustic Science Division’s Wireless Sound Association (WiSA), today announced three new key components to their assortment of industry-leading solutions: WiSA E Falcon Transmitter Module, WiSA Connect Mobile Application, and WiSA Certification Application. Each solution is key in helping consumer electronics brands bring high-performance and interoperable audio components to market, allowing consumers to connect and control simple immersive multichannel audio experiences that are available across a wide range of price points. WiSA Falcon...

Continue reading

CORRECTION — Life & Banc Split Corp. Announces Class A Share Split and an Increase to Total Distributions

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Oct. 10, 2025 (GLOBE NEWSWIRE) — In a news release disseminated on October 6, 2025, there was a typographical error. The reference to “The class A shares are expected to commence trading on an ex-split basis at the opening of trading on October 28, 2025.” should have read “The class A shares are expected to commence trading on an ex-split basis at the opening of trading on October 27, 2025.” No other changes were made. The corrected release follows: (TSX: LBS, LBS.PR.A) Life & Banc Split Corp. (the “Fund”) is pleased to announce its intention to complete a stock split of its class A shares (the “Share Split”) due to the Fund’s strong performance. Class A shareholders of record at the close of business on October 27, 2025 will...

Continue reading

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults.1 UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for use every one or two months for the treatment of schizophrenia in adults.1 This approval marks a significant step towards addressing the unmet needs of people living with BD-I and schizophrenia, underscoring Teva’s ongoing commitment to drive new advances in neuroscience.2PARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Oct. 10, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), announced today that the U.S....

Continue reading

AMG Critical Materials N.V. Announces Sale of Graphit Kropfmühl GmbH to Asbury Carbons

Amsterdam, 10 October 2025 (Regulated Information) — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) and Asbury Carbons Inc. (“Asbury Carbons”) are pleased to announce the signing of a definitive agreement for AMG to sell Graphit Kropfmühl GmbH (“GK”) to Asbury Carbons, a portfolio company of Mill Rock Capital. The transaction reflects an enterprise value of $65 million. GK operates its own graphite mine at its headquarters in Kropfmühl, Germany, and holds a majority stake in a graphite mine in Sri Lanka. Asbury Carbons will assume all GK operations, including approximately 350 employees. For the twelve months ended August 2025, GK generated $65 million in revenue. With this transaction, AMG completes its exit from the natural graphite business. “The sale of GK highlights AMG’s commitment to proactive portfolio management,”...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.